Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:3/15/2019
Start Date:May 1, 2018
End Date:May 2020
Contact:T. Jonathan Yang, MD, PhD
Email:yangt@mskcc.org
Phone:212-639-8157

Use our guide to learn which trials are right for you!

A Randomized Trial of Early, Upfront Palliative Radiation Therapy Versus Standard of Care for Patients With Highest Risk Asymptomatic or Minimally Symptomatic Bone Metastases

The purpose of the study is to compare the outcome of patients who receive standard treatment
versus those who receive preventative radiation and then standard treatment.


Inclusion Criteria:

- Histologically confirmed solid tumor malignancy with greater than 5 sites of
metastatic disease detected on cross-sectional imaging.

- Has high risk bone metastases that are asymptomatic or minimally symptomatic (not
requiring opioids). High risks metastases are defined as: 1. bulkiest sites of osseous
disease ≥ 2cm, 2. disease involving the hip (acetabulum, femoral head, femoral neck),
shoulder (acromion, glenoid, humeral head), or sacroiliac joints 3. disease in long
bones with1/3-2/3 cortical thickness (humerus, radius, ulna, clavicle, femur, tibia,
fibula, metacarpus, phalanges) 4. disease in junctional spine (C7-T1, T12-L1, L5-S1)
and/or disease with posterior element involvement.

- ECOG performance status 0 - 2.

- Age ≥ 18 years.

- Able to provide informed consent.

- Patients at reproductive potential must agree to practice an effective contraceptive
method. Women of childbearing potential must not be pregnant or lactating.

Exclusion Criteria:

- Previous radiotherapy to the intended treatment site that precludes developing a
treatment plan that respects normal tissue tolerances.

- Serious medical co-morbidities precluding radiotherapy.

- Pregnant or lactating women.

- Target lesion(s) is/are complicated bone metastases that include clinical or
radiological evidence of spinal cord compression or impending pathological fracture.

- Leptomeningeal disease.

- Malignant pleural effusion.

- Absolute neutrophil count (ANC) <1.0 K/mcL and platelet count <50 K/mcL at time of
enrollment.

- Patients whose entry to the trial will cause unacceptable clinical delays in their
planned management.
We found this trial at
8
sites
225 Summit Avenue
Montvale, New Jersey 07645
Phone: 212-639-8157
?
mi
from
Montvale, NJ
Click here to add this to my saved trials
136 Mountainview Boulevard
Basking Ridge, New Jersey 07920
Phone: 212-639-8157
?
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Commack, New York 11725
Phone: 212-639-8157
?
mi
from
Commack, NY
Click here to add this to my saved trials
Harrison, New York
Phone: 212-639-8157
?
mi
from
Harrison, NY
Click here to add this to my saved trials
Middletown, New Jersey 07748
Phone: 212-639-8157
?
mi
from
Middletown, NJ
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: T. Jonathan Yang, MD, PhD
Phone: 212-639-8157
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials
Rockville Centre, New York 11570
Phone: 212-639-8157
?
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Uniondale, New York 11553
Phone: 212-639-8157
?
mi
from
Uniondale, NY
Click here to add this to my saved trials